XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Details) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 0 Months Ended 3 Months Ended
Apr. 30, 2013
Stock options [Member]
Apr. 30, 2012
Stock options [Member]
Jan. 31, 2013
Stock options [Member]
Apr. 30, 2013
Stock options [Member]
Minimum [Member]
Apr. 30, 2012
Stock options [Member]
Minimum [Member]
Apr. 30, 2013
Stock options [Member]
Maximum [Member]
Apr. 30, 2012
Stock options [Member]
Maximum [Member]
Jun. 06, 2012
Stock options [Member]
Senior executives [Member]
Apr. 02, 2012
Stock options [Member]
Senior executives [Member]
Feb. 27, 2012
Stock options [Member]
Senior executives [Member]
Apr. 30, 2013
Stock options [Member]
Senior executives [Member]
Apr. 30, 2013
Restricted Stock Units [Member]
Nonemployeedirector
Restricted Stock Units [Abstract]                        
Number of non-employee Directors                       5
Number of common share at vesting date for each grantee (in shares)                       1
Weighted average fair value as of grant date (in dollars per share)                       $ 9.70
Unrecognized compensation expense $ 702,833                     $ 12,501
Restricted stock units transaction activity [Roll Forward]                        
Non-vested, beginning (in units)                       15,465
Granted (in units)                       0
Vested (in units)                       0
Forfeited (in units)                       0
Non-vested, ending (in units)                       15,465
Stock options [Abstract]                        
Vesting rights of awards granted one-third exercisable one year from the grant date and the remaining two-thirds vesting two and three years from grant date, respectively                      
Term of awards                     10 years  
Weighted average grant date fair value per unit (in dollars per unit)               $ 2.91 $ 3.18 $ 2.96 $ 3.14  
Assumptions used [Abstract]                        
Expected term 5 years 5 years                    
Risk-free interest rate (in hundredths)       0.77% 0.88% 1.68% 2.11%          
Expected volatility (in hundredths)       43.00% 43.00% 45.00% 45.00%          
Dividend yield (in hundredths)       2.18% 2.18% 2.93% 2.88%          
Options [Roll Forward]                        
Outstanding at beginning of period (in shares) 1,303,192                      
Granted (in shares) 136,875             3,300 54,625 97,299    
Forfeited (in shares) (32,700)                      
Exercises (in shares) (11,201)                      
Outstanding at end of period (in shares) 1,396,166   1,303,192                  
Exercisable at end of period (in shares) 1,131,964                      
Weighted average exercise price [Roll Forward]                        
Outstanding at beginning of period (in dollars per share) $ 10.3077                      
Granted (in dollars per share) $ 10.2000                      
Forfeited (in dollars per share) $ 11.5690                      
Exercised (in dollars per share) $ 11.0001                      
Outstanding at end of period (in dollars per share) $ 10.2620   $ 10.3077                  
Exercisable at end of period (in dollars per share) $ 10.2382                      
Additional disclosures [Abstract]                        
Outstanding, average remaining life 5 years 22 days   4 years 9 months 29 days                  
Exercisable, average remaining life 4 years 1 month 10 days                      
Outstanding, aggregate intrinsic value 4,381,169                      
Exercisable, aggregate intrinsic value 3,579,270                      
Aggregate intrinsic value of options exercised 26,434                      
Stock option modification cost $ 250,000